Biocept plummets on 1-for-30 reverse stock split
** Shares of oncology diagnostics company Biocept Inc
BIOC.O fell as much as 18.25% to $5.15, hitting a record low
** Says effected a 1-for-30 reverse stock split post market
close of May 16
** Stocks began to trade on split-adjusted basis after
market open on May 17
(Reporting by Raechel Thankam Job)
((RaechelThankam.Job@thomsonreuters.com;))
Recent news on Biocept
See all newsBrief: Biocept Says Trading Of Common Stock Will Be Suspended By Nasdaq At Opening Of Business On Oct 25
U.S. STOCKS ON THE MOVE-Overstock.com, Biocept, Birkenstock
Biocept slumps after filing for bankruptcy protection
Brief: Biocept CEO Antonino Morales Resigns
U.S. STOCKS ON THE MOVE-Albemarle, Novavax, WeWork